MARKET

PBE

PBE

Invesco Dynamic Biotech & Genome ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

76.17
-1.54
-1.98%
Closed 16:00 09/20 EDT
OPEN
76.13
PREV CLOSE
77.70
HIGH
77.04
LOW
75.58
VOLUME
5.31K
TURNOVER
--
52 WEEK HIGH
84.86
52 WEEK LOW
54.41
TOTAL ASSET
307.51M
YTD YIELD
-2.33%
1D
5D
1M
3M
1Y
5Y
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Zacks.com · 5d ago
Illumina Bumping Against Top of Analysts' Price Estimates
GuruFocus News · 08/18 18:26
A Comprehensive Guide to Genomic ETFs
Zacks.com · 07/09 20:04
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.
Benzinga · 06/07 19:25
Biogen’s Alzheimer’s drug wins FDA approval, see which ETFs are in play
Photo by yalax/iStock via Getty Images The U.S. Food and Drug Administration has approved Biogen (BIIB) and Eisai's Aduhelm (aducanumab) to help treat patients who have Alzheimer's disease. The approval
Seekingalpha · 06/07 17:21
Momentum Trade Sinks as Bernstein Warns on Record Valuations
Bloomberg · 02/23 14:44
A New ETF Seeks to Short Volatility While Dodging Total Wipeout
Exchange-traded products that bet against stock volatility have a history of blowing up. A New York-based firm is pitching a novel solution to the problem.
Bloomberg · 02/23 14:42
Invesco’s CEO Sees Opportunity in China, Risk in Bitcoin and SPACs
Martin Flanagan, head of the $1.3 trillion money manager since 2005, talks about how the pandemic has changed business.
Bloomberg · 02/23 11:00
More
No Data
Learn about the latest financial forecast of PBE. Analyze the recent business situations of Invesco Dynamic Biotech & Genome ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-6.7168%
--
1-Week
-6.0909%
--
1-Month
-10.7878%
--
3-Month
-4.8963%
--
6-Month
7.1783%
--
YTD
-2.3282%
--
1-Year
11.1931%
--
3-Year
3.4889%
--
5-Year
0.9705%
--
10-Year
11.7333%
--
Since Inception
9.2415%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
Invesco Dynamic Biotech & Genome ETF
Risk
Medium-high risk
Inception Date
2005-06-23
Benchmark
Dow Jones US Healthcare TR
Advisor Company
Invesco
Custodian
The Bank of New York Mellon
Manager
Hubbard/Jeanette/Seisser